Latest Advances

  • Condition: Malignant Hypertension with Splenic Rupture and Thrombotic Microangiopathy
  • Journal: Medicine
  • Treatment Used: Hemodialysis and Intravenous Antihypertensive Agents
  • Number of Patients: 1
  • Published —
This case report describes a patient with malignant hypertension with splenic rupture and thrombotic microangiopathy that was treated using hemodialysis and intravenous antihypertensive agents.
  • Condition: Takayasu Arteritis-induced Renal Arteritis
  • Journal: Chinese medical journal
  • Treatment Used: Various
  • Number of Patients: 82
  • Published —
In this review of the literature, researchers sought to determine the best treatments for Takayasu arteritis-induced renal arteritis.
  • Condition: Thrombotic Microangiopathy (TMA) Secondary to Systemic Lupus Erythematosus (SLE)
  • Journal: Zhonghua nei ke za zhi
  • Treatment Used: Glucocorticoid Pulse Therapy and Rituximab
  • Number of Patients: 1
  • Published —
This case report discusses a 21-year-old male patient diagnosed with thrombotic microangiopathy (TMA) secondary to systemic lupus erythematosus (SLE) treated with glucocorticoid pulse therapy and rituximab.
  • Condition: Antiphospholipid Syndrome (APS) Nephropathy and Other Thrombotic Microangiopathies (TMA) Among Patients With Systemic Lupus Erythematosus (SLE)
  • Journal: Advances in chronic kidney disease
  • Treatment Used: Complement Inhibition, Mammalian Target of Rapamycin (mTOR) Inhibition, B Cell Depleting Therapy, and Plasma Exchange Therapy
  • Number of Patients: 0
  • Published —
This article discusses antiphospholipid syndrome (APS) and other causes of thrombotic microangiopathy (TMA) in patients with systemic lupus erythematosus (SLE) and lupus nephritis.
  • Condition: Severe and Malignant Hypertension in Primary Atypical Hemolytic Uremic Syndrome (aHUS)
  • Journal: Kidney international
  • Treatment Used: Plasmapheresis, Eculizumab
  • Number of Patients: 165
  • Published —
This study investigated the frequency and severity of hypertension (high blood pressure) in patients with primary atypical hemolytic uremic syndrome (aHUS).
  • Condition: Recovery of Renal Function in a Kidney Transplant Patient
  • Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
  • Treatment Used: Hemodialysis for 4 Months
  • Number of Patients: 1
  • Published —
This case report discusses a patient who underwent ABO-incompatible and living-related renal transplant in which the patient experienced 7 acute kidney injury episodes, including recurrent malignant hypertension, rejection, and infections treated with 4 months of hemodialysis.
Showing 1-6 of 6